FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

The US Food and Drug Administration is urging all patients with smartphone-compatible diabetes devices to check their phone configurations to ensure all safety alerts are being received.

Certain smartphone features such as battery saver, “focus mode” or “do not disturb” may change how alerts are delivered. The Food and Drug Administration (FDA) has issued a safety ...

The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood glucose level alerts from diabetes-related smartphone devices due to ...

and smartphone operating system updates that are not supported by the medical device application. The FDA's safety communication provides recommendations, such as the following, for users of these ...

Making devices that are defect-free and able to withstand years of harsh environments is made more difficult by a combination ...

The US FDA warns users of smartphone-linked diabetes devices like CGMs and insulin pumps of potential health risks due to missed critical alerts. Issues arise from software configuration ...

The FDA is working with diabetes-related medical device manufacturers to ensure that smartphone alert configurations of their devices are carefully evaluated prior to use by patients. The agency ...

On Wednesday, Teladoc Health reported that its 2024 revenue dropped 1% to $2.57 billion. The company projected a revenue ...

The US Food and Drug Administration (FDA) is alerting patients of a safety concern regarding diabetes devices, such as continuous glucose monitors (CGMs), insulin pumps and automated insulin dosing ...